Literature DB >> 2988762

Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.

Y Pommier, L A Zwelling, C S Kao-Shan, J Whang-Peng, M O Bradley.   

Abstract

Intercalator-induced DNA strand breaks in mammalian cells represent topoisomerase II:DNA complexes trapped by intercalators. These complexes are detected as protein-associated DNA single-strand breaks (SSB) and DNA double-strand breaks (DSB) by filter elution. Using Chinese hamster lung fibroblasts (V79 cells) that were treated for 30 min with various concentrations of 4'-(9-acridinylamino)methanesulfon-m-anisidide or 5-iminodaunorubicin, we measured DNA strand breaks (SSB and DSB), sister chromatid exchanges (SCE), mutations at the hypoxanthine:guanine phosphoribosyltransferase locus, and cell killing. Further, we correlated DNA strand breakage with the three other parameters. Both drugs induced SCE, mutations, and cell killing at concentrations which also produced reversible DNA strand breaks. While the quantity of DSB correlated with SCE, mutations, and cytotoxicity for both drugs, we found more SCE, mutations, and cytotoxicity per SSB in cells treated with 5-iminodaunorubicin than in those treated with 4'-(9-acridinylamino)methanesulfon-m-anisidide. These data show that the DSB (but not the SSB) induced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and 5-iminodaunorubicin at DNA topoisomerase II binding sites correlated closely with SCE, mutations, and cell killing and could therefore be responsible for their production.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988762

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Ternary interactions of spermine with DNA: 4'-epiadriamycin and other DNA: anthracycline complexes.

Authors:  L D Williams; C A Frederick; G Ughetto; A Rich
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

Review 2.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin.

Authors:  R Supino; M Mariani; E Prosperi; G Parmiani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Mutagenic and genotoxic effects of Anilofos with micronucleus, chromosome aberrations, sister chromatid exchanges and Ames test.

Authors:  Dilek Akyil; Muhsin Konuk; Yasin Eren; Recep Liman; Esra Sağlam
Journal:  Cytotechnology       Date:  2017-06-12       Impact factor: 2.058

5.  Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.

Authors:  R M Snapka
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Mechanisms of small molecule-DNA interactions probed by single-molecule force spectroscopy.

Authors:  Ali A Almaqwashi; Thayaparan Paramanathan; Ioulia Rouzina; Mark C Williams
Journal:  Nucleic Acids Res       Date:  2016-04-16       Impact factor: 16.971

7.  Dose-response function for Painter's SCE-model.

Authors:  G A Schachtel; W Köhler
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

8.  Induction of sister chromatid exchanges by inhibitors of topoisomerases.

Authors:  M Lim; L F Liu; D Jacobson-Kram; J R Williams
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

9.  Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death.

Authors:  N A Berger; S Chatterjee; J A Schmotzer; S R Helms
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Survival of rat mammary tumor cell clones and DNA strand damage following adriamycin treatment.

Authors:  D P Evans; R E Meyn; S P Tomasovic
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.